RAC 2.31% $1.27 race oncology ltd

To trial Bisantrene on various cancers, page-3

  1. 2,505 Posts.
    lightbulb Created with Sketch. 9446
    This was just a rehash of the last quarterly. As was reiterated in the quarterly we have more than 2 quarters of cash so we don’t desperately need to raise. We have previously stated that we won’t be asking the shareholders for support unless we have demonstrated we are delivering on the new plan. Given the history of the company it is reasonable for the shareholders to be cautious, even though in many ways RAC is a very different animal than it was 6 months ago.

    I have a strong feeling that anyone hoping for a lazy, heavily discounted CR sold to flippers and short term traders will be disappointed.


 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.27
Change
-0.030(2.31%)
Mkt cap ! $210.2M
Open High Low Value Volume
$1.30 $1.30 $1.27 $17.88K 14.01K

Buyers (Bids)

No. Vol. Price($)
1 406 $1.27
 

Sellers (Offers)

Price($) Vol. No.
$1.29 200 1
View Market Depth
Last trade - 11.40am 30/04/2024 (20 minute delay) ?
Last
$1.27
  Change
-0.030 ( 0.35 %)
Open High Low Volume
$1.27 $1.29 $1.27 1343
Last updated 11.40am 30/04/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.